101 related articles for article (PubMed ID: 32007210)
1. Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.
Armstrong TS; Dirven L; Arons D; Bates A; Chang SM; Coens C; Espinasse C; Gilbert MR; Jenkinson D; Kluetz P; Mendoza T; Rubinstein L; Sul J; Weller M; Wen PY; van den Bent MJ; Taphoorn MJB
Lancet Oncol; 2020 Feb; 21(2):e97-e103. PubMed ID: 32007210
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations.
Blakeley JO; Coons SJ; Corboy JR; Kline Leidy N; Mendoza TR; Wefel JS
Neuro Oncol; 2016 Mar; 18 Suppl 2(Suppl 2):ii13-ii20. PubMed ID: 26989128
[TBL] [Abstract][Full Text] [Related]
3. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials clinical outcome assessment endpoints workshop (October 15, 2014, Bethesda MD).
Helfer JL; Wen PY; Blakeley J; Gilbert MR; Armstrong TS
Neuro Oncol; 2016 Mar; 18 Suppl 2(Suppl 2):ii26-ii36. PubMed ID: 26989130
[TBL] [Abstract][Full Text] [Related]
4. A selected review of abstracts from the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology.
Chamberlain MC
CNS Oncol; 2014 Mar; 3(2):109-13. PubMed ID: 25055016
[TBL] [Abstract][Full Text] [Related]
5. Molecular neuro-oncology: a forward-looking perspective.
Wick W; O'Neill T
CNS Oncol; 2013 Nov; 2(6):491-3. PubMed ID: 25054819
[TBL] [Abstract][Full Text] [Related]
6. Ask the Expert: A Recap on Patient-Reported Outcomes.
Cramer H
J Integr Complement Med; 2024 Mar; 30(3):207-208. PubMed ID: 38484316
[No Abstract] [Full Text] [Related]
7. Glioma patient-reported outcome assessment in clinical care.
Tuleasca C; Knisely J; Leroy HA; Hottinger AF; Peciu-Florianu I; Levivier M; Reyns N
Lancet Oncol; 2020 May; 21(5):e230. PubMed ID: 32359495
[No Abstract] [Full Text] [Related]
8. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Erker C; Tamrazi B; Poussaint TY; Mueller S; Mata-Mbemba D; Franceschi E; Brandes AA; Rao A; Haworth KB; Wen PY; Goldman S; Vezina G; MacDonald TJ; Dunkel IJ; Morgan PS; Jaspan T; Prados MD; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e317-e329. PubMed ID: 32502458
[TBL] [Abstract][Full Text] [Related]
9. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.
Brown PD; Gondi V; Pugh S; Tome WA; Wefel JS; Armstrong TS; Bovi JA; Robinson C; Konski A; Khuntia D; Grosshans D; Benzinger TLS; Bruner D; Gilbert MR; Roberge D; Kundapur V; Devisetty K; Shah S; Usuki K; Anderson BM; Stea B; Yoon H; Li J; Laack NN; Kruser TJ; Chmura SJ; Shi W; Deshmukh S; Mehta MP; Kachnic LA;
J Clin Oncol; 2020 Apr; 38(10):1019-1029. PubMed ID: 32058845
[TBL] [Abstract][Full Text] [Related]
11. Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative.
Dirven L; Vos ME; Walbert T; Armstrong TS; Arons D; van den Bent MJ; Blakeley J; Brown PD; Bulbeck H; Chang SM; Coens C; Gilbert MR; Grant R; Jalali R; Leach D; Leeper H; Mendoza T; Nayak L; Oliver K; Reijneveld JC; Le Rhun E; Rubinstein L; Weller M; Wen PY; Taphoorn MJB
Neurooncol Pract; 2021 Aug; 8(4):417-425. PubMed ID: 34277020
[TBL] [Abstract][Full Text] [Related]
12. Glioma.
Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
[TBL] [Abstract][Full Text] [Related]
13. ODF3B affects the proliferation and apoptosis of glioma via the JAK/STAT pathway.
Luan XZ; Yuan SX; Chen XJ; Zhou YR; Tang H; Li JQ; Jiang G; Yang LX; Luo MW; Tian JJ; Wen YQ; Zhang WY; Chen LG; Xiang W; Zhou J
Am J Cancer Res; 2024; 14(3):1419-1432. PubMed ID: 38590411
[TBL] [Abstract][Full Text] [Related]
14. High costs, low quality of life, reduced survival, and room for improving treatment: an analysis of burden and unmet needs in glioma.
Pöhlmann J; Weller M; Marcellusi A; Grabe-Heyne K; Krott-Coi L; Rabar S; Pollock RF
Front Oncol; 2024; 14():1368606. PubMed ID: 38571509
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy.
Dasram MH; Naidoo P; Walker RB; Khamanga SM
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338649
[TBL] [Abstract][Full Text] [Related]
16. LncBIRC3-OT promotes the malignant progression of glioma by interacting with RELA to upregulate stanniocalcin-1 expression.
Wang R; Li Q; Chu X; Li N; Liang H; He F
Heliyon; 2023 Nov; 9(11):e21777. PubMed ID: 38034675
[TBL] [Abstract][Full Text] [Related]
17. Oncological Outcomes, Long-Term Toxicities, Quality of Life and Sexual Health after Pencil-Beam Scanning Proton Therapy in Patients with Low-Grade Glioma.
Willmann J; Leiser D; Weber DC
Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958460
[TBL] [Abstract][Full Text] [Related]
18. Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study.
Retzer A; Baddeley E; Sivell S; Scott H; Nelson A; Bulbeck H; Seddon K; Grant R; Adams R; Watts C; Aiyegbusi OL; Kearns P; Rivera SC; Dirven L; Calvert M; Byrne A
Neurooncol Adv; 2023; 5(1):vdad096. PubMed ID: 37719788
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma.
Wang J; Li S; Guo Y; Zhao C; Chen Y; Ning W; Yang J; Zhang H
Funct Integr Genomics; 2023 Aug; 23(3):279. PubMed ID: 37610668
[TBL] [Abstract][Full Text] [Related]
20. National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
Kim MM; Mehta MP; Smart DK; Steeg PS; Hong JA; Espey MG; Prasanna PG; Crandon L; Hodgdon C; Kozak N; Armstrong TS; Morikawa A; Willmarth N; Tanner K; Boire A; Gephart MH; Margolin KA; Hattangadi-Gluth J; Tawbi H; Trifiletti DM; Chung C; Basu-Roy U; Burns R; Oliva ICG; Aizer AA; Anders CK; Davis J; Ahluwalia MS; Chiang V; Li J; Kotecha R; Formenti SC; Ellingson BM; Gondi V; Sperduto PW; Barnholtz-Sloan JS; Rodon J; Lee EQ; Khasraw M; Yeboa DN; Brastianos PK; Galanis E; Coleman CN; Ahmed MM
Lancet Oncol; 2023 Aug; 24(8):e344-e354. PubMed ID: 37541280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
